Back to Results
First PageMeta Content
Health / Food and Drug Administration / Pharmacology / Otologicals / Norfloxacin / Drug safety / Ofloxacin / Quinolone / MedWatch / Piperazines / Medicine / Chemistry


Document Date: 2009-04-02 10:52:41

Open Document

File Size: 28,53 KB

Share Result on Facebook

Company

S-045 Merck & Co. Inc. / /

Event

FDA Phase / /

Facility

Sumneytown Pike / /

IndustryTerm

drug products / /

MedicalCondition

convulsive seizures / /

Organization

Antimicrobial Products Center for Drug Evaluation and Research / Food and Drug Administration / DEPARTMENT OF HEALTH / Special Pathogen and Transplant Products Office / Division of Special Pathogen / /

Person

Renata Albrecht / Mary Beth Wigley / Christine Lincoln / /

/

Position

Manager / Regulatory Affairs P.O. Box / Director / M.D. Director / /

Product

NOROXIN / norfloxacin / this / S-045 / BLA-20 / /

ProvinceOrState

Maryland / Pennsylvania / /

SocialTag